| Literature DB >> 34544131 |
Ashley S Denney1, Andrew D Weems1, Michael A McMurray1.
Abstract
Life requires the oligomerization of individual proteins into higher-order assemblies. In order to form functional oligomers, monomers must adopt appropriate 3D structures. Molecular chaperones transiently bind nascent or misfolded proteins to promote proper folding. Single missense mutations frequently cause disease by perturbing folding despite chaperone engagement. A misfolded mutant capable of oligomerizing with wild-type proteins can dominantly poison oligomer function. We previously found evidence that human-disease-linked mutations in Saccharomyces cerevisiae septin proteins slow folding and attract chaperones, resulting in a kinetic delay in oligomerization that prevents the mutant from interfering with wild-type function. Here, we build upon our septin studies to develop a new approach for identifying chaperone interactions in living cells, and use it to expand our understanding of chaperone involvement, kinetic folding delays, and oligomerization in the recessive behavior of tumor-derived mutants of the tumor suppressor p53. We find evidence of increased binding of several cytosolic chaperones to a recessive, misfolding-prone mutant, p53(V272M). Similar to our septin results, chaperone overexpression inhibits the function of p53(V272M) with minimal effect on the wild type. Unlike mutant septins, p53(V272M) is not kinetically delayed under conditions in which it is functional. Instead, it interacts with wild-type p53 but this interaction is temperature sensitive. At high temperatures or upon chaperone overexpression, p53(V272M) is excluded from the nucleus and cannot function or perturb wild-type function. Hsp90 inhibition liberates mutant p53 to enter the nucleus. These findings provide new insights into the effects of missense mutations.Entities:
Keywords: zzm321990 Saccharomyces cerevisiaezzm321990 ; bimolecular fluorescence complementation (BiFC); heat shock protein 90 (Hsp90); molecular chaperone; mutant; p53; protein folding; septin
Mesh:
Substances:
Year: 2021 PMID: 34544131 PMCID: PMC8496213 DOI: 10.1093/g3journal/jkab230
Source DB: PubMed Journal: G3 (Bethesda) ISSN: 2160-1836 Impact factor: 3.154
Figure 1BiFC reveals septin–chaperone interactions in living cells. (A) Graphical summary of interactions between VC-tagged septins and VN-tagged cytosolic chaperones in diploid cells coexpressing untagged versions of all proteins. Chaperones that generated discrete fluorescence signal are in bold and underlined. See Table 1 for full dataset. Chaperones are color-coded by family and chaperones from the same family are drawn as the same shape. For the multisubunit chaperones PFD and CCT, if a single subunit interacted with any septin, then the entire complex is indicated as interacting with septins. (B) Micrographs showing discrete fluorescence signals in diploid cells coexpressing Cdc10-VC or the D182N mutant derivative with Ydj1-VN or Cct6-VN. The fluorescence images were inverted to facilitate viewing. Red arrowheads point to bud neck signal. Strains were diploids made by mating YO1057 with H00385 or H00382. (C) Cellular BiFC signal away from bud necks was quantified for diploid cells coexpressing Cdc10-VC or Cdc10(D182N)-VC and the indicated VN-tagged chaperones. The number of cells analyzed for each genotype ranged from 113 to 460. Strains were diploids made by mating YO1057 or H06530 with H00382, H00392, H00390, H00398, H00384, H00394, H00385, or H00396. (D) Representative images of diploid cells (strain M-1622 mated with H00398 or H00385) carrying cdc3(G365R) at one allele of CDC3 and WT CDC3 at the other, a VN-tagged allele of the indicated chaperone at one allele of the chaperone gene locus and an untagged allele at the other, and a low-copy plasmid (G00521 or G00522) encoding Cdc3-VC or Cdc3(G365R)-VC. Plot at right shows quantification of bud neck fluorescence. Twenty cells were analyzed for each genotype.
Septin–chaperone interactions generating discrete BiFC signals
| Chaperone (family) | Major cellular compartment (minor) | Room temperature Septin BiFC interactions (variable) | 37° Septin BiFC interactions (variable) | Published evidence |
|---|---|---|---|---|
| Ssa1 (Hsp70) | Cytosol (Nucleus) | — | — | |
| Ssa2 (Hsp70) | Cytosol (Mitochondria) | Cdc3*, Cdc10, Cdc11, Cdc12, and Shs1 | Cdc3*, Cdc10, Cdc11, Cdc12, and Shs1 | |
| Ssa3 (Hsp70) | Cytosol | Cdc3, Cdc10, Cdc11, Cdc12, and Shs1 | (Cdc10), (Cdc12), and(Shs1) | |
| Ssa4 (Hsp70) | Cytosol (Nucleus) | Cdc3, Cdc10, Cdc11, Cdc12, and Shs1 | Cdc10 and Cdc12 | |
| Ssb1 (Hsp70) | Cytosol | Cdc3, Cdc10, Cdc11, Cdc12, and Shs1 | Cdc3, Cdc10, Cdc11, Cdc12, and Shs1 | Cdc3 (P) ( |
| Ssb2 (Hsp70) | Cytosol | Cdc3, Cdc10, Cdc11, Cdc12, and Shs1 | Cdc3, Cdc10, Cdc11, Cdc12, and Shs1 | Cdc3 (P) ( |
| Sse2 (Hsp70) | Cytosol | Cdc3, Cdc10, Cdc11, Cdc12, and (Shs1) | — | |
| Ssz1 (Hsp70) | Cytosol | — | Not tested | |
| Apj1 (Hsp40) | Cytosol (Nucleus, Mitochondria) | — | Not tested | |
| Djp1 (Hsp40) | Cytosol | Cdc3, Cdc10, (Cdc11), Cdc12, and (Shs1) | Not tested | |
| Jjj1 (Hsp40) | Cytosol (Nucleus, Mitochondria) | — | Not tested | |
| Jjj2 (Hsp40) | Cytosol (Nucleus) | — | Not tested | |
| Sis1 (Hsp40) | Cytosol (Nucleus) | Cdc3, Cdc10, Cdc11, Cdc12, and Shs1 | Not tested | |
| Swa2 (Hsp40) | Cytosol (ER Membrane) | Cdc3, Cdc10, and (Cdc12) | Not tested | |
| Ydj1 (Hsp40) | Cytosol (ER Membrane) | (Cdc3), (Cdc10), Cdc11, Cdc12, and (Shs1) | (Cdc11) and (Cdc12) | Cdc10 (F) ( |
| Zuo1 (Hsp40) | Cytosol (Nucleus) | Cdc3, Cdc10, Cdc11, Cdc12, and Shs1 | Cdc3, Cdc10, Cdc11, Cdc12, and (Shs1) | |
| Hsp12 (small) | Cytosol (Nucleus) | Cdc3, Cdc10, Cdc11, Cdc12, and Shs1 | Not tested | Cdc3 (F) ( |
| Hsp26 (small) | Cytosol (Nucleus) | Cdc3*, Cdc10, Cdc11, Cdc12*, and Shs1 | Not tested | |
| Hsp31 (small) | Cytosol | (Cdc3), Cdc10, Cdc11, Cdc12, and Shs1 | (Cdc3), Cdc10, Cdc11, and (Cdc12) | Cdc3 (P) ( |
| Hsp32 (small) | Cytosol | — | Not tested | |
| Hsp33 (small) | Cytosol | (Cdc3) and (Cdc10) | Not tested | |
| Hsp42 (small) | Cytosol | — | Not tested | |
| Sno4 (small) | Cytosol | — | Not tested | |
| Hsp82 (Hsp90) | Cytosol (Mitochondria) | Cdc3*, Cdc10*, Cdc11*, Cdc12*, and Shs1* | Cdc3*, Cdc10*, Cdc11*, and Cdc12* | Cdc12 (P) ( |
| Hsc82 (Hsp90) | Cytosol | Cdc3*, Cdc10*, Cdc11*, Cdc12*, and Shs1* | Cdc3*, Cdc10*, Cdc11*, Cdc12*, Shs1* | |
| Hsp104 (AAA+) |
Cytosol (Nucleus) | Cdc3*, Cdc10*, Cdc11*, Cdc12*, and Shs1* | Cdc3*, Cdc10*, Cdc11*, Cdc12*, and (Shs1*) | Cdc11 (F) ( |
| CCT/TRiC (Type II chaperonin): | Cytosol | (Cdc3•), (Cdc10•), and (Cdc12•) | (Cdc10•), (Cdc11•), and (Cdc12•) | Cdc3 (P) ( |
| Cct2 | — | (Cdc11•) | ||
| Cct3 | — | (Cdc10•) and (Cdc12•) | Cdc3 (P) ( | |
| Cct4 | — | — | ||
| Cct6 | — | (Cdc10•) | Cdc3 (P) ( | |
| Cct7 | (Cdc3•), (Cdc10•), and (Cdc12•) | (Cdc10•), (Cdc11•), and (Cdc12•) | ||
| Prefoldin/GimC complex: | Cytosol | Cdc3, Cdc10, Cdc11, Cdc12, and Shs1 | (Cdc10) | |
| Gim3 | Cdc3, Cdc10, Cdc11, Cdc12, and Shs1 | — | Cdc3 (F) ( | |
| Gim4 | – | (Cdc10) | Cdc3 (P) ( | |
| Gim5 | Cdc10, (Cdc11), and (Cdc12) | — | Cdc3 (P) ( | |
| Pfd1 | (Cdc10) and(Cdc12) | — | ||
| Yke2 | (Cdc3), (Cdc10), and (Cdc12) | — | Cdc10 (F) ( | |
| Lhs1 (Hsp70) | ER lumen | — | — | |
| Hlj1 (Hsp40) | ER membrane | — | Not tested | |
| Sec63 (Hsp40) | ER membrane | Cdc3, Cdc10, Cdc11, Cdc12, and Shs1 | Not tested | |
| Ecm10 (Hsp70) | Mitochondria | — | Not tested | |
| Ssq1 (Hsp70) | Mitochondria | — | Not tested | |
| Jac1 (Hsp40) | Mitochondria | — | Not tested | |
| Jid1 (Hsp40) | Mitochondria | — | Not tested | |
| Mdj1 (Hsp40) | Mitochondria | — | Not tested | |
| Hsp78 (AAA+) | Mitochondria | — | Not tested | Cdc3 (P) ( |
| Mcx1 (AAA+) | Mitochondria | — | — | |
| Hsp60 (Type I chaperonin) | Mitochondria | — | Not tested | |
| Pam18 (Hsp40) | Inner mitochondrial membrane | — | Cdc3 | Cdc12 (F) ( |
For multisubunit complexes, cumulative interactions are listed in the same row, and individual tested subunits are listed below.
Our interpretation of the literature regarding the major subcellular localization for the chaperone in question, with minor localizations given in parenthesis.
“—,” no discrete signal. *, fluorescence signal appeared as multiple cortical rings; •, punctate signal. Interactions generating fluorescence signal in only a subset of cells are indicated in parenthesis.
(F), physical; (G), functional. Where the interaction could not be attributed to a specific subunit within a multisubunit chaperone, the septin interactor is listed on the same row as the multisubunit chaperone.
The published experiment used a combination of anti-Ssb1 and -Ssb2 antibodies (Stein ).
Figure 3Effects of the V272M and R273H mutations on p53 nuclear localization, oligomerization, and function. (A) Nuclear mKate2 fluorescence in yJM3164 cells carrying a plasmid encoding GAL1/10-driven p53-mKate2-VC (H3.29) or p53(V272M)-mKate2-VC (pMAM67). Cells were imaged at 30-min intervals following induction with galactose at 24°. Lines connect median values; for clarity of viewing, the positions on the x axis were slightly “nudged” so that the two samples do not overlap on the plot. The schematic illustrates accumulation of nuclear and cytosolic p53 over time. (B) Steady-state nuclear mKate2 fluorescence of yJM3164 cells carrying plasmids encoding the indicated alleles of p53-mKate2-Venus and grown to mid-log phase at 30° or 37°. Blue lines denote median values. Vertical line separates 30° from 37°. Plasmids were pMAM85, “WT”; pMAM87, “R273H”; pMAM86, “V272M”; pMAM104, “V272M R273H.” (C) As in (B) but with cells of strain Y0134 coexpressing two p53 alleles fused to mKate2 and the indicated Venus fragments. Venus fluorescence here indicates physical interaction (BiFC). Left plot, total p53 (mKate2) and BiFC (Venus) nuclear fluorescence. Right plot, BiFC (Venus) nuclear signal normalized to total p53 (mKate2) nuclear signal. Blue lines denote median values. Vertical lines separate genotypes. Bold vertical lines separate 30° from 37°. Plasmids were pMAM98, “WT-VN”; pMAM82, “WT-VC”; pMAM84, “R273H-VC”; pMAM83, “V272M-VC.” (D) Schematic of p53 transcriptional reporter strains RBy33 and RBy159. Binding of properly folded p53 to a repressed promoter activates transcription of the URA3 gene product, leading to colony growth on medium lacking uracil, or inhibition of growth on medium containing FOA. (E) Colony growth at 30° and 37° by RBy33 cells carrying plasmids encoding the indicated alleles of p53 on medium selective for the plasmids “-Leu” or selective for the plasmid and p53 reporter activity “-Leu –Ura.” Plasmids were pLS76, “WT”; pMAM69, “V272M”; pMAM79, “R273H”; pMAM77, “V272M R273H.” (F) Colony growth at 30° and 37° by diploid cells with the URA3 reporter of p53 activity carrying plasmids encoding the indicated alleles of p53, together with WT p53 plasmid, on solid medium selective for the plasmids “-Leu -Trp” or selective for the plasmids and counter-selective for p53 reporter activity “-Leu -Trp + FOA.” Plasmids were pMAM78 and pLS76, “WT”; pMAM69, “V272M”; pMAM79, “R273H”; pMAM77, “V272M R273H.” Strains were diploids made by mating RBy33 cells carrying pLS76, pMAM69, pMAM79, or pMAM77 with RBy159 cells carrying pMAM78.
Figure 2Coexpression of WT p53 fails to rescue the folding defects of the p53(V272M) mutant at high temperature. (A) Illustration of split-DHFR p53 construct. TH5 cells are dfr1Δ and proliferate only when exogenous dTMP is present or p53 folds well enough to reconstitute active DHFR. (B) Colony growth at 30° and 37° by fivefold serially diluted TH5 cells carrying plasmids encoding the indicated p53 split DHFR alleles spotted on solid synthetic medium selective for the plasmids and lacking dTMP. Plasmids were G00598, “DHFR-WT”; G00604, “DHFR-V272M”; G00599, “DHFR-Y220C”; G00605, “DHFR-R273H.” (C) As in (B), but with cells also carrying a plasmid encoding WT p53 (pLS76) or an empty vector (“EV,” pRS415) on solid medium selective for the plasmids and either containing “+” or lacking “−” dTMP at 37°. (D) As in (C) except cells were grown in liquid medium without dTMP at 37° in a flat-bottom 96-well plate. Optical density at 600 nm was recorded at 5-min intervals over 21 h for 6 replicate cultures per genotype and plotted as mean (thick line) and upper and lower bounds of the 95% C.I. (thin lines).
Figure 4Cytosolic chaperone-p53 interactions in living cells. (A) Representative micrographs of p53–chaperone BiFC interactions in cells cultured at 30° and expressing Hsp82-VN, Sis1-VN, or Cct7-VN and carrying plasmids encoding the indicated p53-mKate2-VC alleles. Total p53 (mKate2) fluorescence images were false-colored blue and BiFC (Venus) fluorescence images were false-colored orange. Prior to overlay, brightness and contrast were adjusted equivalently for each set of images. Plasmids were pMAM110, “WT”; pMAM112, “R273H”; pMAM111, “V272M.” Strains were diploids made by mating BY4742 cells carrying the plasmids with H00398, H06680, or H00383. (B) BiFC (Venus) signal normalized to total p53 (mKate2) signal in cells cultured at 30° carrying plasmids encoding the indicated p53-mKate2-VC alleles together with the indicated VN-tagged chaperone. Blue lines denote median values. Vertical lines group the samples imaged with the same settings (LED intensity and exposure time). The subcellular location where the BiFC interaction was quantified is indicated below. Plasmids were pMAM110, “WT”; pMAM112, “R273H”; pMAM111, “V272M.” Strains were diploids made by mating BY4742 cells carrying the plasmids with H00399, “Hsc82”; H00388, “Ssa2”; H00383, “Cct7”; H00384, “Hsp104”; H00398, “Hsp82”; H00395, “Ssb1”; H00394, “Ssb2”; H06680, “Sis1”; H00385, “Ydj1”; H00396, “Zuo1”; or H06684, “Hsp12.”
p53–chaperone interactions assayed by BiFC
| Chaperone (family) | Major cellular compartment (minor) | p53 BiFC interactions | Published evidence |
|---|---|---|---|
| Ssa1 (Hsp70) | Cytosol (Nucleus) | — | P, F (reviewed in |
| Ssa2 (Hsp70) | Cytosol (Mitochondria) | WT•, V272M•, and R273H• | |
| Ssa3 (Hsp70) | Cytosol | — | |
| Ssa4 (Hsp70) | Cytosol (Nucleus) | — | |
| Ssb1 (Hsp70) | Cytosol | WT°, V272M°, and R273H° | |
| Ssb2 (Hsp70) | Cytosol | WT°, V272M°, and R273H° | |
| Sse2 (Hsp70) | Cytosol | — | |
| Ssz1 (Hsp70) | Cytosol | — | |
| Apj1 (Hsp40) | Cytosol (Nucleus, Mitochondria) | — | P, F (reviewed in |
| Djp1 (Hsp40) | Cytosol | — | |
| Jjj1 (Hsp40) | Cytosol (Nucleus, Mitochondria) | — | |
| Jjj2 (Hsp40) | Cytosol (Nucleus) | — | |
| Sis1 (Hsp40) | Cytosol (Nucleus) | WT °•*, V272M°•, and R273H °•* | |
| Swa2 (Hsp40) | Cytosol (ER Membrane) | — | |
| Ydj1 (Hsp40) | Cytosol (ER Membrane) | WT°•, V272M°•, and R273H°• | |
| Zuo1 (Hsp40) | Cytosol (Nucleus) | WT°•, V272M°•, and R273H°• | |
| Hsp12 (small) | Cytosol (Nucleus) | WT°*, V272M°*, and R273H°* | P for human αB-crystallin ( |
| Hsp26 (small) | Cytosol (Nucleus) | — | |
| Hsp31 (small) | Cytosol | — | |
| Hsp32 (small) | Cytosol | — | |
| Hsp33 (small) | Cytosol | — | |
| Hsp42 (small) | Cytosol | — | |
| Sno4 (small) | Cytosol | — | |
| Hsp82 (Hsp90) | Cytosol (Mitochondria) | WT°•, V272M°•, and R273H°• | P, F (reviewed in ( |
| Hsc82 (Hsp90) | Cytosol | WT°•, V272M°•, and R273H°• | |
| Hsp104 (AAA+) | Cytosol (Nucleus) | WT•, V272M•, and R273H• | F in yeast ( |
| Cct7 (CCT/TRiC; Type II Chaperonin) | Cytosol | WT•, V272M•, and R273H• | P, F ( |
| Gim 3 (Prefoldin/GimC) | Cytosol | — |
Our interpretation of the literature regarding the major subcellular localization for the chaperone in question, with minor localizations given in parenthesis.
Measured at 30°. “—,” no discrete signal. “°,” fluorescence signal appeared as diffuse cytosolic; “•,” punctate cytosolic signal; “°•,” both diffuse and punctate cytosolic signal; “*,” nuclear signal.
(P), physical; (F), functional.
Figure 5Overexpression of specific chaperones inhibits p53(V272M) function. (A) Colony growth at 30° of fivefold serially diluted diploid cells with the URA3 reporter of p53 activity carrying plasmids encoding the indicated alleles of p53, together with the indicated GAL1/10-driven chaperone plasmid or an empty vector, on solid galactose medium selective for the plasmids “-Leu -Trp” or selective for the plasmids and p53 reporter activity “-Leu -Trp –Ura.” Plasmids were pLS76, “WT”; pMAM69, “V272M”; pRS424 and pRS314, “Empty Vector”; G00630, “Hsp82”; G00799, “Hsc82”; G00633, “Ssa2”; G00789, “Ssa4”; G00632, “Sis1”; G00353, “Ydj1”; G00061, “Hsf1ΔN”; G00631, “Hsp104”; G00634, “Ssb2”; G00620, “Cct7”; G00635, “Zuo1”; G00627, “Hsp12”; G00628, “Hsp26”; G00629, “Hsp31.” Strains were diploids made by mating RBy33 cells carrying pLS76 or pMAM69 with RBy159 cells carrying the GAL1/10-driven chaperone plasmid or empty vector. (B) SDS-PAGE and immunoblot analysis of total protein extracts from diploid cells carrying a plasmid encoding p53(V272M) (pMAM69) together with a GAL1/10-driven Hsp82 plasmid (G00630), a GAL1/10-driven Hsc82 plasmid (G00799), or an empty vector (pRS424, “EV”) grown to mid-log phase at 30° in medium with galactose to induce overexpression. The membrane was first probed for hexahistidine-tagged Hsp82 and Hsc82 and subsequently stained with Ponceau. (C) Ratio of nuclear to cytosolic mKate2 signal in diploid cells carrying a plasmid encoding p53(V272M)-mKate2-Venus together with the indicated GAL1/10-driven chaperone plasmid or an empty vector. Cells were grown to mid-log phase at 30° with galactose to overexpress chaperones prior to imaging. “Toxic” denotes chaperones whose overexpression renders p53 inhibitory to colony growth independent of p53 function. Blue lines denote median values. Plasmids were pMAM86, “p53(V272M)”; pRS424, “Empty Vector”; G00353, “Ydj1”; G00630, “Hsp82”; G00633, “Ssa2”; G00799, “Hsc82”; G00634, “Ssb2”; G00631, “Hsp104”; G00632, “Sis1”; G00627, “Hsp12”; G00635, “Zuo1”; G00629, “Hsp31”; G00789, “Ssa4”; G00628, “Hsp26”; G00620, “Cct7.” Strains were diploids made by mating yJM3164 cells carrying pMAM86 with yJM1838 cells carrying the indicated GAL1/10-driven chaperone plasmid or empty vector. (D) Top, nuclear and cytosolic mKate2 fluorescence in diploid cells carrying a plasmid encoding p53(V272M)-mKate2-Venus (pMAM86) and an empty vector (“EV,” pRS424) or a plasmid encoding tandem affinity purification-(TAP-)tagged Sis1 (G00632). Cells were grown to mid-log phase at 30° with galactose to overexpress Sis1 prior to imaging. A single outlier (Y = 115) was omitted from the EV Nucleus dataset to facilitate viewing on the Y-axis. Blue lines denote median values. Strains were diploids made by mating yJM3164 cells carrying pMAM86 to yJM1838 cells carrying G00632 or pRS424. Bottom, as in (B) but with diploid cells carrying plasmids encoding the indicated alleles of p53 together with the Sis1-TAP plasmid or an empty vector, as in (A) or the plot above, and probed for p53, the cytosolic protein Pgk1, and hexahistidine-tagged Sis1-TAP. Asterisk, proteolytic degradation products derived from p53-mKate2-Venus. (E) Representative micrographs of vacuolar mKate2 signal in diploid cells expressing p53(V272M)-mKate2-Venus (pMAM86) and GAL1/10-driven Sis1 (G00632) or GAL1/10-driven Zuo1 (G00616), prepared as in (C). Nucleus (Htb2-mNeon) fluorescence images were false-colored blue and p53 (mKate2) fluorescence images were false-colored orange. Prior to overlay, brightness, and contrast were adjusted equivalently for each set of images. Strain was a diploid made by mating yJM3164 cells carrying pMAM86 to yJM1838 cells carrying G00632 or G00616.
Figure 6Chaperone inhibition liberates p53 from cytosolic compartmentalization. (A) Ratio of nuclear to cytosolic mKate2 signal in yJM3164 cells carrying plasmids encoding the indicated alleles of p53-mKate2-Venus. Cells were grown to mid-log phase at 37° with 2.5 µg/ml radicicol or equivalent volume of DMSO prior to imaging. Blue lines denote median values. Vertical lines separate genotypes. Plasmids were pMAM85, “WT”; pMAM86, “V272M”; pMAM87, “R273H”; pMAM104, “V272M R273H.” (B) RBy33 cells carrying plasmids encoding the indicated alleles of p53 were grown to mid-log phase at 30° and lysed. Proteins were separated by SDS-PAGE. After electrophoretic transfer, the membrane was probed for p53 and the cytosolic protein Pgk1. Plasmids were pLS76, “WT”; pMAM69, “V272M”; pMAM79, “R273H”; pMAM77, “V272M R273H.” (C) Representative micrographs of vacuolar mKate2 signal in yJM3164 cells carrying plasmids encoding the indicated alleles of p53-mKate2-Venus and treated with 5 µg/ml radicicol, prepared as in (A). Nucleus (Htb2-mNeon) fluorescence images were false-colored blue and p53 (mKate2) fluorescence images were false-colored orange. Prior to overlay, brightness, and contrast were adjusted equivalently for each set of images. Plasmids were pMAM85, “WT”; pMAM86, “V272M”; pMAM87, “R273H”; pMAM104, “V272M R273H.”